Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alka-5 is an approved proprietary Ayurvedic herbal syrup developed and marketed by Charak Pharma. Formulated as a natural urinary alkalizer, it is designed to maintain normal urine pH balance and support urinary tract health. The product is a multi-ingredient formulation containing key herbal components such as Yavakshara (Hordeum vulgare ash), Shwetparpati, Gokshura (Tribulus terrestris), Dhanyak (Coriandrum sativum), and Jeerak (Cuminum cyminum). It is indicated for the management of dysuria (painful or burning urination), urinary tract infections (UTIs), urethritis, cystitis, sunstroke, and urinary calculi (kidney stones). Alka-5 works by soothing burning urination, reducing inflammation and pain, exhibiting antibacterial activity, and facilitating the flushing of urinary calculi through its diuretic and lithotriptic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alka-5.